Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI assessment of diagnostic eye drops on lens water circulation in presbyopia-related aging
ACTRN12623000297628Phase 4Completed
- Sponsor
- The University of Auckland
- Start
- Jun 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tropicamide, cyclopentolate and pilocarpine in presbyopia (3 arms), sponsored by The University of Auckland. Primary endpoints: Change in lens gradient of refractive index, Change in lens water distribution and 1 more. Started Jun 2023; status: completed.
02
Drugs
tropicamidecyclopentolatepilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on ACTRN12623000297628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000297628.